In a statement, Rubberex said its shareholders in an extraordinary general meeting held on Wednesday unanimously approved the proposed purchase, as well as its subsequent proposed diversification into the healthcare business and name change to Hextar Healthcare Bhd. He added that the healthcare business is complementary and synergistic to its core glove business, in line with the group’s overall growth strategy of venturing into other income-generated businesses that are profitable and sustainable for the long-term. Meanwhile, Rubberex’s largest shareholder Datuk Eddie Ong Choo Meng commented that as a testament to the group’s commitment to the healthcare sector, it proposed and obtained its shareholders’ approval for a name change to Hextar Healthcare. “This is to better reflect the group’s core business and future undertakings into the broader healthcare sector moving forward. Reszon is principally involved in the manufacturing of innovative vitro diagnostics test kits, Covid-19 rapid test kits and test kits specialising in infectious disease diagnosis and drug abuse screening for medical professionals and clinical diagnostic markets.

Source: The Edge Markets September 15, 2022 00:21 UTC